InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,297.10
(
-0.21%
)
US TECH 100
18,069.64
(
-0.26%
)
Dow Jones
39,869.38
(
-0.10%
)
Brent Oil
83.15
(
0.59%
)
Bitcoin
65,116.18
(
-1.73%
)
Post# of 459223
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Lacey1

Send PM Follow Ignore
Followers 3
Posts 13
Boards Moderated 0
Alias Born 11/21/2022

Lacey1

Re: sumbuysumsell post# 453547

Wednesday, 03/06/2024 12:44:23 PM

Wednesday, March 06, 2024 12:44:23 PM

Post# of 459223
93% of those patients taking the trial are still taking it after the trial. Hardly a failure.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • May 16, 2024 8:13 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM

Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM

Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM

Start posting your company's news
Only $200 per official company press release!